{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:23:34Z","timestamp":1770506614135,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2002,5,1]],"date-time":"2002-05-01T00:00:00Z","timestamp":1020211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2002,5]]},"DOI":"10.1007\/s11906-002-0014-5","type":"journal-article","created":{"date-parts":[[2007,5,24]],"date-time":"2007-05-24T06:18:38Z","timestamp":1179987518000},"page":"245-249","source":"Crossref","is-referenced-by-count":8,"title":["Functional tests for primary aldosteronism: Value of captopril suppression"],"prefix":"10.1007","volume":"4","author":[{"given":"Marie-Claude","family":"Racine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Douville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Lebel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"14_CR1","first-page":"6","volume":"45","author":"JW Conn","year":"1955","unstructured":"Conn JW: Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 1955, 45:6\u201317.","journal-title":"J Lab Clin Med"},{"key":"14_CR2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","volume":"21","author":"RD Gordon","year":"1994","unstructured":"Gordon RD, Stowasser M, Tunny TJ, et al.: High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994, 21:315\u2013318.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"14_CR3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00045415-199907000-00012","volume":"7","author":"WF Young Jr","year":"1999","unstructured":"Young WF Jr: Primary aldosteronism: A common and curable form of hypertension. Cardiol Rev 1999, 7:207\u2013214. An excellent review of the clinical features, investigation, and treatment of primary aldosteronism. The use of the ratio of plasma aldosterone to renin values has yielded a 10-fold increase in the average annual rate of diagnosis at the Mayo Clinic during the past 8 years, compared with the period between 1960 and 1991.","journal-title":"Cardiol Rev"},{"key":"14_CR4","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s11906-001-0045-3","volume":"3","author":"M Stowasser","year":"2001","unstructured":"Stowasser M: Primary aldosteronism: rare bird or common cause of secondary hypertension? Curr Hypertens Rep 2001, 3:230\u2013239. A comprehensive overview of historical perspectives, prevalence of subtypes including familial varieties, and identification of genetic mutations causing primary aldosteronism.","journal-title":"Curr Hypertens Rep"},{"key":"14_CR5","first-page":"1863","volume":"85","author":"CE Fardella","year":"2000","unstructured":"Fardella CE, Mosso L, Gomez-Sanchez C, et al.: Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 2000, 85:1863\u20131867.","journal-title":"J Clin Endocrinol Metab"},{"key":"14_CR6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.jhh.1001013","volume":"14","author":"PO Lim","year":"2000","unstructured":"Lim PO, Dow E, Brennan G, et al.: High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J Hum Hypertens 2000, 14:311\u2013315.","journal-title":"J Hum Hypertens"},{"key":"14_CR7","first-page":"2854","volume":"85","author":"KC Loh","year":"2000","unstructured":"Loh KC, Koay ES, Khaw MC, et al.: Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 2000, 85:2854\u20132859.","journal-title":"J Clin Endocrinol Metab"},{"key":"14_CR8","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1001\/archinte.1993.00410180075008","volume":"153","author":"MH Weinberger","year":"1993","unstructured":"Weinberger MH, Fineberg NS: The diagnosis of primary aldosteronism and separation of two major subtypes. Arch Intern Med 1993, 153:2125\u20132129.","journal-title":"Arch Intern Med"},{"issue":"Suppl 3","key":"14_CR9","first-page":"S275","volume":"3","author":"J Menard","year":"1985","unstructured":"Menard J, Guyenne TT, Corvol P, et al.: Direct immunometric assay of active renin in human plasma. J Hypertens Suppl 1985, 3(Suppl 3):S275\u2013278.","journal-title":"J Hypertens Suppl"},{"key":"14_CR10","first-page":"1367","volume":"9","author":"A Morganti","year":"1987","unstructured":"Morganti A, Turolo L, Pulazzini E, Zanchetti A: Comparative measurements of immunoreactive renin, plasma renin activity and angiotensin II in human plasma. Clin Exp Hypertens A 1987, 9:1367\u20131381.","journal-title":"Clin Exp Hypertens A"},{"key":"14_CR11","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/clinchem\/45.6.847","volume":"45","author":"J Deinum","year":"1999","unstructured":"Deinum J, Derkx FH, Schalekamp MA: Improved immunoradiometric assay for plasma renin. Clin Chem 1999, 45:847\u2013854.","journal-title":"Clin Chem"},{"key":"14_CR12","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/01.HYP.37.6.1440","volume":"37","author":"M Agharazii","year":"2001","unstructured":"Agharazii M, Douville P, Grose JH, Lebel M: Captopril suppression versus salt loading in confirming primary aldosteronism. Hypertension 2001, 37:1440\u20131443. The first report comparing the efficacy of the captopril test with the oral salt-loading approach for the confirmation of the diagnosis of primary aldosteronism in a series of 49 well-documented patients. There was a significant correlation between plasma aldosterone values of the salt-loaded patients and the values 2 hours after captopril administration. Plasma aldosterone cumulative distribution curves were not different between the two suppression tests. The results showed that the captopril suppression test is as effective as sodium loading in confirming the diagnosis of primary aldosteronism.","journal-title":"Hypertension"},{"key":"14_CR13","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0025-6196(11)62105-8","volume":"76","author":"VM Montori","year":"2001","unstructured":"Montori VM, Schwartz GL, Chapman AB, et al.: Validity of the aldosterone-renin ratio used to screen for primary aldosteronism. Mayo Clin Proc 2001, 76:877\u2013882.","journal-title":"Mayo Clin Proc"},{"key":"14_CR14","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1055\/s-2007-1019037","volume":"14","author":"M Lebel","year":"1982","unstructured":"Lebel M, Grose JH: Angiotensin II effect on plasma steroids in selective hypoaldosteronism. Horm Metab Res 1982, 14:432\u2013436.","journal-title":"Horm Metab Res"},{"key":"14_CR15","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archinte.1971.00310210056004","volume":"128","author":"DC Kem","year":"1971","unstructured":"Kem DC, Weinberger MH, Mayes DM, Nugent CA: Saline suppression of plasma aldosterone in hypertension. Arch Intern Med 1971, 128:380\u2013386.","journal-title":"Arch Intern Med"},{"key":"14_CR16","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/01.HYP.37.3.856","volume":"37","author":"PO Lim","year":"2001","unstructured":"Lim PO, Farquharson CA, Shiels P, et al.: Adverse cardiac effects of salt with fludrocortisone in hypertension. Hypertension 2001, 37:856\u2013861. An original study involving 29 hypertensive subjects with raised aldosterone\/renin ratios in whom the effect of salt on cardiac target-organ damage was studied. The results showed that salt with fludrocortisone increased QT dispersion and impaired left ventricular diastolic function, raising the possibility that salt may have blood pressure-independent adverse cardiac effects in susceptible hypertensive subjects.","journal-title":"Hypertension"},{"key":"14_CR17","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1210\/jcem-57-5-892","volume":"57","author":"DF Lyons","year":"1983","unstructured":"Lyons DF, Kem DC, Brown RD, et al.: Single dose captopril as a diagnostic test for primary aldosteronism. J Clin Endocrinol Metab 1983, 57:892\u2013896.","journal-title":"J Clin Endocrinol Metab"},{"key":"14_CR18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1536\/ihj.26.549","volume":"26","author":"S Naomi","year":"1985","unstructured":"Naomi S, Iwaoka T, Umeda T, et al.: Clinical evaluation of the captopril screening test for primary aldosteronism. Jpn Heart J 1985, 26:549\u2013556.","journal-title":"Jpn Heart J"},{"key":"14_CR19","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ng0992-66","volume":"2","author":"RP Lifton","year":"1992","unstructured":"Lifton RP, Dluhy RG, Powers M, et al.: Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nat Genet 1992, 2:66\u201374.","journal-title":"Nat Genet"},{"key":"14_CR20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1440-1681.1992.tb00462.x","volume":"19","author":"M Stowasser","year":"1992","unstructured":"Stowasser M, Gordon RD, Tunny TJ, et al.: Familial hyperaldosteronism type II: five families with a new variety of primary aldosteronism. Clin Exp Pharmacol Physiol 1992, 19:319\u2013322.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"14_CR21","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1210\/jcem-51-5-1190","volume":"51","author":"A Ganguly","year":"1980","unstructured":"Ganguly A, Zager PG, Luetscher JA: Primary aldosteronism due to unilateral adrenal hyperplasia. J Clin Endocrinol Metab 1980, 51:1190\u20131194.","journal-title":"J Clin Endocrinol Metab"},{"key":"14_CR22","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0002-9343(87)90891-6","volume":"83","author":"D Farge","year":"1987","unstructured":"Farge D, Chatellier G, Pagny JY, et al.: Isolated clinical syndrome of primary aldosteronism in four patients with adrenocortical carcinoma. Am J Med 1987, 83:635\u2013640.","journal-title":"Am J Med"},{"key":"14_CR23","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0889-8529(18)30425-0","volume":"17","author":"WF Young Jr","year":"1988","unstructured":"Young WFJr, Klee GG: Primary aldosteronism. Diagnostic evaluation. Endocrinol Metab Clin North Am 1988, 17:367\u2013395.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"14_CR24","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0002-9610(85)80186-0","volume":"149","author":"M Abecassis","year":"1985","unstructured":"Abecassis M, McLoughlin MJ, Langer B, Kudlow JE: Serendipitous adrenal masses: prevalence, significance, and management. Am J Surg 1985, 149:783\u2013788.","journal-title":"Am J Surg"},{"key":"14_CR25","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0039-6060(96)80033-X","volume":"120","author":"WF Young Jr","year":"1996","unstructured":"Young WF Jr, Stanson AW, Grant CS, et al.: Primary aldosteronism: adrenal venous sampling. Surgery 1996, 120:913\u2013919.","journal-title":"Surgery"},{"key":"14_CR26","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/S0039-6060(97)90218-X","volume":"122","author":"GB Thompson","year":"1997","unstructured":"Thompson GB, Grant CS, van Heerden JA, et al.: Laparoscopic versus open posterior adrenalectomy: a case-control study of 100 patients. Surgery 1997, 122:1132\u20131136.","journal-title":"Surgery"},{"key":"14_CR27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00004872-200103000-00001","volume":"19","author":"PO Lim","year":"2001","unstructured":"Lim PO, Young WF, MacDonald TM: A review of the medical treatment of primary aldosteronism. J Hypertens 2001, 19:353\u2013361. An extensive review of the medical treatment of primary aldosteronism based on a Medline and Embase search. The available therapeutic arsenal, including aldosterone antagonists, allows adequate control of blood pressure in many hypertensive patients, specially those with idiopathic adrenal hyperplasia who otherwise have resistant hypertension despite several drug therapies.","journal-title":"J Hypertens"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-002-0014-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-002-0014-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-002-0014-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T08:23:38Z","timestamp":1587543818000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-002-0014-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,5]]}},"alternative-id":["14"],"URL":"https:\/\/doi.org\/10.1007\/s11906-002-0014-5","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,5]]}}}